Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19
March 30, 2020
Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
New Brunswick, NJ – Johnson & Johnson (NYSE: JNJ) (the Company) today, Monday, March 30th, 2020, announced the selection of a lead coronavirus (COVID-19) vaccine candidate from constructs it has been working on since January 2020.
Coronavirus.
